Candidates for ablation for symptomatic atrial fibrillation who have severe obesity should be considered for bariatric surgery prior to ablation, a new study suggests.
A large matched-cohort study in patients with type 2 diabetes and obesity finds that metabolic surgery confers significant improvements in all prespecified events plus marked reductions in weight, HbA1c, and use of diabetes and cardiovascular medications.
Americans’ awareness of the links between body weight and heart health is spotty, a national survey shows. But at least one finding underscores an opportunity for heart-healthy change.
Patients will now have a single point of entry for evidence-based weight management.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Multisite phosphorylation alters adipocyte metabolism via a kinase called S6K1. This pathway could be an attractive target for therapeutic development.
Cleveland Clinic endocrinologists see improved clinical outcomes and patient satisfaction when shared medical appointments are part of the treatment plan for obese patients. An in-depth look at why.
An independent association between obesity and cardiometabolic risk has been tough to prove. Researchers just made the best case yet by using Mendelian randomization to overcome the usual limits of observational studies.
Obesity is like any other chronic disease. Getting the right treatment can make a big difference, says Cleveland Clinic’s W. Scott Butsch, MD.
Bartolome Burguera, MD, PhD, was compelled to become an endocrinologist after seeing the suboptimal care and untoward bias against people suffering from obesity. Today, he serves as Cleveland Clinic’s Director of Obesity Programs in the Endocrinology & Metabolism Institute.
A number of popular diets are reviewed as well as studies evaluating the effect of various diets on weight loss, diabetes and cardiovascular risk factors.